Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Gastro Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Gastro Other
    Everolimus Is an Effective Treatment Option for Patients With Pancreatic Neuroendocrine Tumours: Presented at ESMO-GI - (DGDispatch)
    Proton Pump Inhibitors May Increase Risk for Clostridium difficile Outbreaks: Presented at ICC - (DGDispatch)
    Efficacy of Vaccination Against Traveller's Diarrhoea: Presented at ESPID - (DGDispatch)
    CT Colonography May Help High-Risk Patients Adhere to Follow-up Screening - (DGNews)
    Sevelamer Carbonate Approved in EU for Patients With Chronic Kidney Disease - (DGNews)

    News archive

     Recent webcasts/CME - Gastro Other
    • Biologics in Crohn's Disease: Treating Early, Treating Long-Term
    • Long-Term Sustainability Using Biologics in Crohn's Disease
    • Recent Updates in Crohn's Disease: Optimising Remission, Healing, and Quality of Life
    • Advances in the Management of Postoperative Ileus: Reducing the Clinical and Economic Burden
      Irritable Bowel Syndrome with Constipation (IBS-C): Improving Patient Care Assessment and Management

      Webcasts/CME archive

       Recent cases - Gastro Other
        An Unexpected Cause of Iron Deficiency Detected by Capsule Endoscopy
        Acute Abdominal Pain in a Patient Receiving Enoxaparin
        Splenic Rupture Following Colonoscopy, A Rare Complication
        Accurate Localization of Life Threatening Colonic Hemorrhage During Nuclear Medicine Bleeding Scan as an Aid to Selective Angiography
        Disabling Osteomalacia and Myopathy as the Only Presenting Features of Celiac Disease: A Case Report

        Cases archive
          




        my personal edition > gastro other > news
        divider

          E-Mail this DGDispatch to a colleague

        DGDispatch


        Vitamin E May Improve Omeprazole Treatment of Moderate to Severe Erosive Oesophagitis: Presented at UEGW

        By Adrian Burton

        MADRID, SPAIN -- November 11, 2003 -- Vitamin E may improve the results of alternate day omeprazole 20 mg maintenance treatment for moderate to severe erosive oesophagitis. This finding was from an Iranian study, presented here November 5th at the 11th United European Gastroenterology Week

        Over 80% of patients with moderate to severe erosive oesophagitis relapse on currently available treatment, so improved therapeutic strategies are needed.

        "There are studies showing that the mucosal damage in oesophagitis is mediated primarily by free radicals," explained Shahram Mirmomen, MD, Associate Professor in Gastroenterology, Imam Khomeini Hospital, Tehran University of Medical Science, Tehran, Iran. "And vitamin E has antioxidant properties. This was [our] basis for using vitamin E to increase the mucosal resistance in reflux."

        Fifty-eight patients with moderate to severe erosive oesophagitis were enrolled in a double-blind placebo-controlled trial, in which 29 participants received omeprazole 20 mg every other day plus vitamin E 800 mg/day, and 29 received omeprazole 20 mg every other day plus a daily placebo. The groups were age and sex matched. At entry, all patients had been cured of endoscopically confirmed oesophagitis (Grade 2 or 3 on the Los Angeles scale) by anti-secretory therapy.

        All patients underwent endoscopic control to assess relapse rates at 24 and 48 weeks, or when they presented with symptoms.

        At 24 weeks, 82.8% of the vitamin-E-group patients were still in remission compared to only 58.6% in the placebo group (P = .04). Similarly, at 48 weeks, 79.3% and 55.2% were in remission (P = .04). Further, 68.9% of patients in the vitamin E group were symptom-free, compared to 48.2% in the placebo group.

        "This study shows that vitamin E plus low-dose omeprazole is more effective than omeprazole alone for maintenance of moderate to severe osophagitis. But this is a very preliminary study, and I think a larger one is necessary to confirm this," said Dr. Mirmomen.

        The results could be of immediate use to physicians treating patients with recurrent oesophagitis, however. Vitamin E is cheap, widely available, safe, and may even help prevent other diseases such as cardiovascular disease, cancer and dementia -- so nothing would be lost by adding it to the treatment regimen.

        Such treatment might also allow the dose of proton pump inhibitor used to be lowered.


        [Study Title: Combination of Omeprazole 20 mg Every Other Day and Vitamin E in Preventing Endoscopic Relapse of Erosive Esophagitis: A Placebo-Controlled Double-Blind Study. Abstract Wed-OP-G-228]



        E-Mail this DGDispatch to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send